Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical News Today (MNT)
An estimated 5% of U.S. adults have consumed at least one potentially hepatotoxic herbal supplement in the past month, raising concerns about liver health risks associated with unregulated botanical products.
Clinical Pharmacology August 26th 2024
Cleveland Clinic Journal of Medicine (CCJM)
Emerging data suggest that lactated Ringer’s is associated with improved health outcomes and may be superior to normal saline in acute pancreatitis management.
Emergency Medicine August 19th 2024
HealthDay
Liver injuries tied to botanical supplements are on the rise, with cases nearly tripling in a decade. Healthcare providers should be aware of this growing concern and its implications for patient care.
Family Medicine/General Practice August 12th 2024
Journal of the American College of Cardiology (JACC)
In patients with both cirrhosis and atrial fibrillation, apixaban initiation was associated with lower rates of major bleeding compared to rivaroxaban or warfarin, without compromising thromboembolic protection.
Cardiology August 5th 2024
Despite its theoretical benefits, IV albumin has not shown consistent superiority over crystalloid solutions in sepsis management, prompting a reevaluation of fluid resuscitation strategies in critical care settings.
Emergency Medicine July 16th 2024
Medical Xpress
Incidence rates provide a truer measure of medication-induced liver injury, revealing misclassifications in traditional methods. This study highlights the need for closer monitoring of certain medications using real-world healthcare data.
Hepatology July 2nd 2024